Artificial Intelligence in Depression - Medication Enhancement

Completed · Not applicable

Conditions studied: Depression

In brief

This study will determine the safety and potential effectiveness of a digital health platform aimed at improving treatment outcomes for patients with depression by assisting physicians with clinical decision making about depression treatment.

Key facts

Study ID

NCT04655924

Run by

Aifred Health

People needed

94

Starts

2022-06-16

Expected to finish

2023-12-31

Last updated by the study team

2024-01-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• VA New Haven, VA Connecticut Healthcare System — West Haven, Connecticut, United States
• South Florida Veterans Affairs — Miami, Florida, United States
• Emory University — Atlanta, Georgia, United States
• University of Michigan, Michigan Medicine — Ann Arbor, Michigan, United States
• Salem VAMC — Salem, Virginia, United States
• CAMH: The Centre for Addiction and Mental Health — Toronto, Ontario, Canada
• CIUSSS de l'Est-de-l'Île-de-Montréal — Montreal, Quebec, Canada
• CIUSSS De Centre Ouest De L'île de Montréal — Montreal, Quebec, Canada
• McGill University Health Care Centre (MUHC) — Montreal, Quebec, Canada
• CIUSSS De L'Ouest de L'île de Montréal — Montreal, Quebec, Canada
• Douglas Mental Health University Institute — Verdun, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.